https://ambrygen.com/company/press-releases 2026-07-31T13:45:00+00:00 https://ambrygen.com/company/press-release/1/ambry-genetics-announces-508-first-r-cystic-fibrosis-test-59-assay-detects-the-most-common-cystic-fibrosis-mutation 2017-05-23T15:12:35+00:00 https://ambrygen.com/company/press-release/2/ambry-genetics-expands-services-to-diagnose-life-threatening-lung-diseases 2017-05-31T14:27:01+00:00 https://ambrygen.com/company/press-release/3/ambry-genetics-expands-services-to-diagnose-life-threatening-lung-diseases-1 2017-05-31T14:31:28+00:00 https://ambrygen.com/company/press-release/4/surfing-leads-to-medical-breakthrough-ambry-genetics-amp-newport-surf-camp-team-up-to-get-children-with-cystic-fibrosis-surfing 2017-05-31T14:33:03+00:00 https://ambrygen.com/company/press-release/5/first-clinical-genetic-test-for-idiopathic-pulmonary-fibrosis-launched-by-ambry-genetics 2017-05-31T14:34:57+00:00 https://ambrygen.com/company/press-release/6/ambry-genetics-creates-new-business-division-to-support-biopharmaceutical-research 2017-05-31T14:37:00+00:00 https://ambrygen.com/company/press-release/7/ambry-genetics-announces-next-generation-sequencing-services-for-support-of-pharmacogenomics-research 2017-05-31T14:38:42+00:00 https://ambrygen.com/company/press-release/8/ambry-genetics-introduces-sequence-capture-for-high-throughput-sequencing-applications-on-multiple-next-gen-sequencing-platforms 2017-05-31T14:41:08+00:00 https://ambrygen.com/company/press-release/9/ambry-genetics-announces-illumina-cspro-certification-for-ga-sequencing 2017-05-31T14:42:44+00:00 https://ambrygen.com/company/press-release/10/ambry-genetics-announces-the-addition-of-array-cgh-services-through-partnership-with-baylor-college-of-medicine 2017-05-31T14:44:29+00:00 https://ambrygen.com/company/press-release/11/ambry-genetics-announces-launch-of-chromosomal-microarray-to-offer-whole-genome-analysis 2017-05-31T14:46:18+00:00 https://ambrygen.com/company/press-release/12/ambry-genetics-announces-certified-service-provider-status-for-agilent-microarrays 2017-06-01T09:48:52+00:00 https://ambrygen.com/company/press-release/13/agilent-technologies-appoints-ambry-genetics-as-first-certified-service-provider-for-agilent-s-target-enrichment-system-for-next-gen-sequencing 2017-06-01T09:51:34+00:00 https://ambrygen.com/company/press-release/14/ambry-genetics-and-softgenetics-form-exclusive-alliance-for-extended-bioinformatics-support-for-next-generation-sequencing-projects 2017-06-01T10:07:56+00:00 https://ambrygen.com/company/press-release/15/ambry-genetics-announces-launch-of-their-stemarray-product-and-services-for-high-resolution-characterization-of-human-stem-cells 2017-06-01T10:10:52+00:00 https://ambrygen.com/company/press-release/16/ambry-genetics-and-raindance-technologies-announce-partnership-for-diagnostics-and-genomics-services-utilizing-the-rdt-1000-for-sequence-enrichment-and-targeted-resequencing-validation 2017-06-01T10:12:59+00:00 https://ambrygen.com/company/press-release/17/ambry-genetics-launches-first-x-linked-intellectual-disabilities-diagnostics-using-next-generation-sequencing 2017-06-01T10:15:11+00:00 https://ambrygen.com/company/press-release/18/ambry-genetics-announces-the-addition-of-illumina-hiseq-2000-and-first-510-k-approved-beadexpress-r-to-its-sequencing-and-genotyping-capabilities 2017-06-01T10:18:01+00:00 https://ambrygen.com/company/press-release/19/ambry-genetics-becomes-first-certified-service-provider-in-us-for-nimblegen-seqcap-ez-exome 2017-06-01T10:19:46+00:00 https://ambrygen.com/company/press-release/20/the-mauli-ola-foundation-mof-announced-as-agent-of-change-award-recipients-for-2010-surfer-poll-presented-by-samsung-and-verizon-wireless 2017-06-01T10:22:31+00:00 https://ambrygen.com/company/press-release/21/ambry-genetics-announces-launch-of-illumina-hiseq-2000-next-gen-sequencing-services 2017-06-01T10:24:07+00:00 https://ambrygen.com/company/press-release/22/ambry-genetics-amp-raindance-technologies-expand-collaboration-to-address-adme-analysis 2017-06-01T10:29:36+00:00 https://ambrygen.com/company/press-release/23/labs-inc-announces-alliance-with-ambry-genetics-to-expand-testing-solutions-for-the-reproductive-health-industry 2017-06-01T10:33:35+00:00 https://ambrygen.com/company/press-release/24/ambry-genetics-is-first-authorized-customer-service-provider-in-new-ion-torrent-csp-program 2017-06-01T10:37:57+00:00 https://ambrygen.com/company/press-release/25/ambry-genetics-adds-certification-of-roche-nimblegen-cgh-dna-methylation-gene-expression-and-chip-chip-to-service-portfolio 2017-06-01T10:43:05+00:00 https://ambrygen.com/company/press-release/26/cell-line-genetics-and-ambry-genetics-announce-exclusive-global-agreement-for-sales-of-ambry-genetics-stemarray-and-related-services 2017-06-01T10:56:54+00:00 https://ambrygen.com/company/press-release/27/ambry-genetics-announces-launch-of-their-cancerarray-product-and-services-utilizing-acgh-technology 2017-06-01T11:05:22+00:00 https://ambrygen.com/company/press-release/28/ambry-genetics-raindance-s-new-thunderstorm-system-for-high-throughput-next-generation-targeted-sequencing-services 2017-06-01T11:09:58+00:00 https://ambrygen.com/company/press-release/29/ambry-genetics-raindance-s-new-thunderstorm-system-for-high-throughput-next-generation-targeted-sequencing-services-1 2017-06-01T11:09:59+00:00 https://ambrygen.com/company/press-release/30/ambry-genetics-first-to-offer-exome-sequencing-service-for-clinical-diagnostics 2017-06-01T11:14:41+00:00 https://ambrygen.com/company/press-release/31/raindance-technologies-and-ambry-genetics-launch-industry-s-most-comprehensive-dna-sequencing-panel-for-adme-research 2017-06-01T11:17:39+00:00 https://ambrygen.com/company/press-release/32/agilent-technologies-signs-agreement-to-supply-target-enrichment-system-to-ambry-genetics-for-exome-sequencing 2017-06-01T11:19:45+00:00 https://ambrygen.com/company/press-release/33/ambry-genetics-turns-to-emc-isilon-for-next-generation-storage-of-gene-sequencing 2017-06-01T11:28:37+00:00 https://ambrygen.com/company/press-release/34/ambry-genetics-launches-illumina-miseq-next-gen-sequencing-services 2017-06-01T11:30:10+00:00 https://ambrygen.com/company/press-release/35/ambry-genetics-reports-results-from-clinical-diagnostic-exome-testing-of-three-patients 2017-06-01T11:32:18+00:00 https://ambrygen.com/company/press-release/36/ambry-genetics-reports-specific-results-from-clinical-diagnostic-exome-testing-of-patients-at-kennedy-krieger-institute 2017-06-01T11:34:08+00:00 https://ambrygen.com/company/press-release/37/ambry-genetics-introduces-first-tier-exome-sequencing-test 2017-06-01T11:36:00+00:00 https://ambrygen.com/company/press-release/38/ambry-genetics-initiates-fluidigm-based-genomic-research-services-for-gene-expression-snp-genotyping-and-sample-prep-for-targeted-sequencing 2017-06-01T11:40:22+00:00 https://ambrygen.com/company/press-release/39/ernst-amp-young-announces-finalists-for-the-2012-entrepreneur-of-the-year-awards-in-orange-county 2017-06-01T11:45:41+00:00 https://ambrygen.com/company/press-release/40/ambry-genetics-catches-the-clinical-sequencing-wave 2017-06-01T11:47:44+00:00 https://ambrygen.com/company/press-release/41/the-clinical-exome-the-brass-ring-of-molecular-testing 2017-06-01T11:49:27+00:00 https://ambrygen.com/company/press-release/42/ambry-genetics-chairman-and-ceo-charles-dunlop-honored-with-rare-champion-award-at-global-genes-project-s-champions-of-hope-gala 2017-06-01T11:53:53+00:00 https://ambrygen.com/company/press-release/43/diagnosing-rare-disorders-using-next-generation-sequencing 2017-06-01T11:59:14+00:00 https://ambrygen.com/company/press-release/44/milestone-10-000-diagnostic-amp-100-000-genomic-ngs-samples 2017-06-01T12:00:43+00:00 https://ambrygen.com/company/press-release/45/somatic-mutation-analysis 2017-06-01T12:01:54+00:00 https://ambrygen.com/company/press-release/46/ambry-genetics-leading-the-way-with-clinical-next-generation-sequencing 2017-06-01T12:03:46+00:00 https://ambrygen.com/company/press-release/47/ceocfo-magazine-interview-with-charles-dunlop 2017-06-01T12:05:11+00:00 https://ambrygen.com/company/press-release/48/ambry-genetics-launches-brca-1-amp-2-single-genes-and-ngs-panel-offerings 2017-06-01T12:06:35+00:00 https://ambrygen.com/company/press-release/49/ambry-genetics-will-vigorously-defend-against-brca1-and-brca2-gene-patent-infringement-suit 2017-06-01T12:10:23+00:00 https://ambrygen.com/company/press-release/50/ambry-genetics-reaffirms-status-as-worldwide-leader-in-hereditary-cancer-testing-with-new-renal-pancreatic-and-pgl-pcc-panels 2017-06-01T12:11:48+00:00 https://ambrygen.com/company/press-release/51/ambry-genetics-sues-myriad-genetics-for-violating-federal-antitrust-laws 2017-06-01T12:15:10+00:00 https://ambrygen.com/company/press-release/52/ambry-genetics-prevails-in-preliminary-injunction-motion-filed-by-myriad-genetics 2017-06-01T12:23:00+00:00 https://ambrygen.com/company/press-release/53/ambry-genetics-launches-a-new-generation-of-clinical-exome-sequencing 2017-06-01T12:24:25+00:00 https://ambrygen.com/company/press-release/54/ambry-genetics-publishes-data-supporting-use-of-hereditary-cancer-panel-testing 2017-06-01T12:26:24+00:00 https://ambrygen.com/company/press-release/55/researchers-suggest-payors-and-clinicians-should-choose-brca-labs-that-behave-ethically-make-data-available 2017-06-01T12:29:03+00:00 https://ambrygen.com/company/press-release/56/ambry-genetics-to-be-featured-on-innovations-with-ed-begley-jr 2017-06-01T12:30:59+00:00 https://ambrygen.com/company/press-release/57/ambry-genetics-announces-title-sponsorship-for-battle-for-the-breasts-to-raise-awareness-in-the-fight-against-breast-cancer 2017-06-01T12:32:49+00:00 https://ambrygen.com/company/press-release/58/ambry-genetics-partners-in-hereditary-cancer-research-registry-prompt 2017-06-01T12:35:24+00:00 https://ambrygen.com/company/press-release/59/ambry-publishes-data-on-high-detection-rates-for-their-clinical-exome-sequencing-assay 2017-06-01T13:41:34+00:00 https://ambrygen.com/company/press-release/60/ambry-genetics-launches-clinically-valuable-new-approach-to-cardiovascular-genetic-testing 2017-06-01T13:43:04+00:00 https://ambrygen.com/company/press-release/61/ambry-genetics-announces-settlement-in-brca1-2-gene-patent-infringement-case 2017-06-01T13:44:36+00:00 https://ambrygen.com/company/press-release/62/ambry-announces-newly-published-data-on-hereditary-ovarian-cancer-and-multi-gene-panels 2017-06-01T13:46:18+00:00 https://ambrygen.com/company/press-release/63/ambry-genetics-acquires-progeny-software-llc 2017-06-01T13:48:28+00:00 https://ambrygen.com/company/press-release/64/ey-announces-award-winners-for-entrepreneur-of-the-year-r-2015-orange-county 2017-06-01T13:52:18+00:00 https://ambrygen.com/company/press-release/65/worlds-top-female-surfers-compete-for-125-000-donation-in-genetic-testing-vouchers-to-clinics-in-the-battle-for-the-breasts 2017-06-01T13:55:10+00:00 https://ambrygen.com/company/press-release/66/ambry-genetics-unveils-comprehensive-educational-resource-supporting-people-with-hereditary-breast-and-ovarian-cancer 2017-06-01T14:04:08+00:00 https://ambrygen.com/company/press-release/67/ambry-genetics-shows-expanded-tp53-testing-identifies-more-carriers-raising-questions-about-clinical-definition-of-li-fraumeni-syndrome 2017-06-01T14:05:27+00:00 https://ambrygen.com/company/press-release/68/ambry-genetics-launches-new-epilepsy-genetic-testing-panels 2017-06-01T14:08:24+00:00 https://ambrygen.com/company/press-release/69/standup-for-the-cure-miami-event-on-november-7-to-raise-awareness-and-funding-for-breast-cancer-research 2017-06-01T14:10:08+00:00 https://ambrygen.com/company/press-release/70/surfing-champion-coco-ho-wins-50-000-donation-in-hereditary-breast-cancer-testing-vouchers-for-cancer-foundation-as-part-of-mauli-ola-foundation-s-battle-for-the-breasts 2017-06-01T14:11:19+00:00 https://ambrygen.com/company/press-release/71/ambry-genetics-launches-cost-free-cloud-based-software-to-help-clinicians-and-researchers-maximize-genetic-and-family-history-data 2017-06-01T14:13:13+00:00 https://ambrygen.com/company/press-release/72/ambry-genetics-launches-new-neurodevelopmental-genetic-testing 2017-06-01T14:15:26+00:00 https://ambrygen.com/company/press-release/73/ambry-genetics-unveils-its-super-lab-one-of-the-largest-most-state-of-the-art-commercial-laboratories-in-the-world 2017-06-01T14:21:05+00:00 https://ambrygen.com/company/press-release/74/ambry-genetics-to-present-seven-abstracts-at-upcoming-acmg-annual-clinical-genetics-meeting 2017-06-01T14:23:26+00:00 https://ambrygen.com/company/press-release/75/ambry-genetics-launches-ambryshare-the-largest-disease-specific-public-database-of-sequenced-human-genomes-increasing-the-understanding-of-hereditary-breast-and-ovarian-cancer-10-fold 2017-06-01T14:24:48+00:00 https://ambrygen.com/company/press-release/76/ambry-genetics-shares-new-data-on-genetic-causes-for-neurodevelopmental-conditions-further-adding-to-growing-body-of-evidence-in-neurology 2017-06-01T14:25:48+00:00 https://ambrygen.com/company/press-release/77/charles-dunlop-of-ambry-genetics-assumes-role-of-president-dr-aaron-elliott-named-ceo 2017-06-01T14:28:15+00:00 https://ambrygen.com/company/press-release/78/ambry-genetics-and-prominent-oncology-research-collaborators-to-share-new-hereditary-cancer-data-at-upcoming-american-society-of-clinical-oncology-asco-annual-meeting 2017-06-01T14:30:01+00:00 https://ambrygen.com/company/press-release/79/ambry-genetics-and-collaborators-publish-vital-processes-and-data-to-better-understand-new-gene-associated-with-unexplained-neurodevelopmental-disorder 2017-06-01T14:41:04+00:00 https://ambrygen.com/company/press-release/80/ambry-genetics-donates-125-000-in-breast-cancer-genetic-testing-vouchers-to-mauli-ola-foundation 2017-06-01T14:43:49+00:00 https://ambrygen.com/company/press-release/81/ambry-genetics-ceo-aaron-elliott-receives-oc-business-journal-s-innovator-of-the-year-award 2017-06-01T14:44:54+00:00 https://ambrygen.com/company/press-release/82/ambry-genetics-launches-comprehensive-multi-gene-test-for-hereditary-prostate-cancer 2017-06-01T14:46:35+00:00 https://ambrygen.com/company/press-release/83/ambry-genetics-publishes-data-from-20-000-cases-supporting-sanger-sequencing-of-variants-following-ngs 2017-06-01T14:47:49+00:00 https://ambrygen.com/company/press-release/84/ambry-genetics-big-data-sharing-program-now-available-for-public-download 2017-06-01T14:49:48+00:00 https://ambrygen.com/company/press-release/85/ambry-genetics-launches-new-site-for-cohort-recruitment 2017-06-01T14:51:07+00:00 https://ambrygen.com/company/press-release/86/ambry-genetics-celebrates-translational-research-at-acmg-2017-presents-13-abstracts-and-plans-to-launch-a-personalized-genomic-test 2017-06-01T14:52:40+00:00 https://ambrygen.com/company/press-release/87/ambry-genetics-recruits-patient-cohorts-to-discover-new-links-between-genes-and-autism 2017-06-01T14:54:25+00:00 https://ambrygen.com/company/press-release/88/progeny-genetics-names-new-chief-executive-officer 2017-06-01T14:55:54+00:00 https://ambrygen.com/company/press-release/89/ambry-launches-innovative-tumor-germline-testing-to-help-clinicians-guide-patient-treatment 2017-06-05T15:04:37+00:00 https://ambrygen.com/company/press-release/91/ambry-genetics-amp-northshore-university-healthsystem-partner-to-accelerate-precision-medicine-in-preventive-care 2017-09-12T18:27:50+00:00 https://ambrygen.com/company/press-release/92/ambry-announces-new-research-grant-program-in-their-commitment-towards-advancing-science-and-research-at-nsgc-2017 2017-09-12T18:32:16+00:00 https://ambrygen.com/company/press-release/93/ambry-genetics-announces-integration-with-fdna-to-advance-precision-medicine 2017-09-14T20:18:22+00:00 https://ambrygen.com/company/press-release/94/ambry-presents-scientific-discovery-to-enhance-clinical-practice-at-american-society-for-human-genetics-annual-meeting-ashg 2017-10-16T18:34:24+00:00 https://ambrygen.com/company/press-release/95/ambry-genetics-advances-patient-care-through-telemedicine-genetic-counseling-services-amp-pwnhealth-partnership 2017-10-27T20:41:42+00:00 https://ambrygen.com/company/press-release/96/ambry-genetics-mitochondrial-disease-research-may-help-develop-treatments-sooner 2017-11-30T17:11:20+00:00 https://ambrygen.com/company/press-release/99/ambry-presents-research-expanding-our-understanding-of-gene-disease-relationships-at-the-san-antonio-breast-cancer-symposium 2018-01-18T10:12:08+00:00 https://ambrygen.com/company/press-release/102/ambry-genetics-in-collaboration-with-mayo-clinic-and-northshore-university-healthsystem-announce-important-research-contributing-to-breast-cancer-risk-prediction 2018-06-04T13:47:56+00:00 https://ambrygen.com/company/press-release/105/jama-oncology-publishes-ambry-s-results-detailing-genes-associations-with-hereditary-breast-and-ovarian-cancer 2018-08-16T14:36:13+00:00 https://ambrygen.com/company/press-release/106/ambry-genetics-presents-research-on-the-importance-of-reclassifying-disease-causing-genes-at-the-national-society-of-genetic-counselors-nsgc-annual-meeting 2018-11-15T08:19:22+00:00 https://ambrygen.com/company/press-release/109/my-gene-counsel-and-ambry-genetics-join-forces-to-bridge-the-gap-between-direct-to-consumer-testing-and-medical-grade-genetic-testing 2019-03-18T09:54:47+00:00 https://ambrygen.com/company/press-release/112/intalere-teams-with-ambry-genetics-to-offer-healthcare-providers-advanced-genetic-testing-for-cancer-risk-assessment 2019-04-09T08:48:59+00:00 https://ambrygen.com/company/press-release/113/ambry-genetics-research-highlights-need-for-expanded-genetic-testing-payer-coverage-for-patients-at-risk-for-hereditary-breast-and-ovarian-cancer 2019-05-01T12:16:40+00:00 https://ambrygen.com/company/press-release/114/research-from-ambry-genetics-amp-mayo-clinic-reveals-differences-in-the-prevalence-of-breast-cancer-genes-among-racial-and-ethnic-populations 2019-05-29T10:05:19+00:00 https://ambrygen.com/company/press-release/115/konica-minolta-to-join-global-oncogenic-gene-panel-research 2019-06-05T09:25:45+00:00 https://ambrygen.com/company/press-release/117/ambry-genetics-data-reveal-that-expanding-genetic-testing-guidelines-could-identify-more-patients-with-increased-risks-of-cancer 2019-08-26T08:39:26+00:00 https://ambrygen.com/company/press-release/118/ambry-genetics-makes-scientific-breakthrough-and-launches-paired-rna-and-dna-testing-for-hereditary-cancer 2019-09-30T15:17:32+00:00 https://ambrygen.com/company/press-release/119/new-data-from-ambry-genetics-demonstrates-impact-of-first-major-advancement-in-over-10-years-to-increase-diagnostic-yield-in-genetic-testing-for-hereditary-cancer-risk 2019-10-15T08:47:18+00:00 https://ambrygen.com/company/press-release/120/ambry-genetics-published-data-that-finds-adding-rna-genetic-testing-provides-more-accurate-actionable-results-for-patients-who-receive-dna-testing-for-hereditary-cancer-risk 2019-10-23T09:21:58+00:00 https://ambrygen.com/company/press-release/121/new-data-from-ambry-genetics-show-substantial-increase-in-diagnostic-yield-further-supporting-the-routine-use-of-rna-genetic-testing-for-hereditary-cancer-panels 2019-11-05T08:43:27+00:00 https://ambrygen.com/company/press-release/122/caris-life-sciences-and-ambry-genetics-partner-to-advance-cancer-care 2019-12-03T10:34:01+00:00 https://ambrygen.com/company/press-release/123/new-data-from-ambry-genetics-showed-concurrent-rna-and-dna-testing-identified-more-patients-with-hereditary-breast-cancer-than-dna-testing-alone 2019-12-10T08:32:47+00:00 https://ambrygen.com/company/press-release/124/ambry-genetics-receives-new-york-state-approval-rnainsight 2019-12-13T12:49:44+00:00 https://ambrygen.com/company/press-release/125/invicro-llc-announces-dr-matthew-silva-as-new-chief-executive-officer-and-dr-jack-hoppin-is-named-president-of-konica-minolta-precision-medicine 2019-12-26T15:16:44+00:00 https://ambrygen.com/company/press-release/126/invicro-and-paige-partner-to-offer-comprehensive-tissue-biomarker-profiling-services 2020-01-15T14:55:45+00:00 https://ambrygen.com/company/press-release/127/invicro-scientists-work-on-imaging-synaptic-density-in-schizophrenia-published-in-nature-communications 2020-01-28T12:32:46+00:00 https://ambrygen.com/company/press-release/128/first-prospective-study-shows-rnainsight-identifies-more-patients-with-increased-risk-for-hereditary-cancer-than-dna-only-testing 2020-02-27T10:31:18+00:00 https://ambrygen.com/company/press-release/129/konica-minolta-precision-medicine-inc-acquires-backpack-health-assets 2020-05-19T12:22:18+00:00 https://ambrygen.com/company/press-release/132/best-company-women-culture-2020 2020-12-17T15:28:35+00:00 https://ambrygen.com/company/press-release/139/konica-minolta-precision-medicine-appoints-jonathan-usuka-chief-strategy-amp-informatics-officer 2021-08-09T16:02:48+00:00 https://ambrygen.com/company/press-release/141/konica-minolta-precision-medicine-announces-name-change-to-realm-idx 2021-09-14T18:08:54+00:00 https://ambrygen.com/company/press-release/142/ambry-genetics-publishes-43-000-patient-study-showing-combined-rna-and-dna-analysis-identifies-patients-who-are-high-risk-for-cancer-but-would-have-been-missed-by-dna-testing-alone 2022-09-09T11:47:55+00:00 https://ambrygen.com/company/press-release/143/ambrys-new-reproductive-health-program 2022-10-17T12:39:17+00:00 https://ambrygen.com/company/press-release/145/unilabs-and-ambry-agreement 2023-01-25T12:22:13+00:00 https://ambrygen.com/company/press-release/146/lifestrands-genomics-and-ambry-provide-lab-testing-for-singapores-national-precision-medicine-programme 2023-04-18T09:26:00+00:00 https://ambrygen.com/company/press-release/147/ambry-genetics-unveils-new-insights-ashg 2023-10-31T07:53:01+00:00 https://ambrygen.com/company/press-release/148/ambry-genetics-announces-a-collaboration-with-tempus-to-advance-paired-germline-and-somatic-testing-services-for-medical-oncologists 2024-03-11T10:50:34+00:00 https://ambrygen.com/company/press-release/149/ambry-genetics-and-pacbio-announce-collaboration-to-sequence-up-to-7-000-human-genomes-aimed-at-providing-answers-for-families-battling-rare-diseases-consortium-selects-leading-genomics-companies-to-s 2024-05-15T07:00:48+00:00 https://ambrygen.com/company/press-release/150/ambry-genetics-announces-new-multiomic-exome-test-for-improved-rare-disease-detection 2024-08-15T11:11:55+00:00 https://ambrygen.com/company/press-release/151/ambry-genetics-announces-new-hereditary-cancer-test-menu-at-nsgc-annual-conference 2024-09-16T07:51:29+00:00 https://ambrygen.com/company/press-release/152/letter-from-tom-schoenherr 2024-11-04T13:04:53+00:00 https://ambrygen.com/company/press-release/153/ambry-genetics-expands-its-award-collection-with-three-new-comparably-best-place-to-work-honors-for-2024 2024-12-12T10:36:41+00:00 https://ambrygen.com/company/press-release/154/ambry-genetics-data-supports-functional-study-of-brca2-helping-improve-variant-classification-for-hereditary-brca2-linked-cancers 2025-01-03T11:03:40+00:00 https://ambrygen.com/company/press-release/155/new-study-shows-impact-of-ambry-genetics-patient-for-life-program-on-rare-disease-diagnosis 2025-05-23T05:16:03+00:00 https://ambrygen.com/company/press-release/156/ambry-genetics-care-program-validated-for-accuracy-in-identifying-high-risk-patients-for-hereditary-cancer-testing 2025-06-13T05:24:57+00:00 https://ambrygen.com/company/press-release/157/ambry-genetics-announces-improved-ehr-integrated-breast-cancer-risk-assessment-solution 2025-09-29T06:58:54+00:00 https://ambrygen.com/company/press-release/158/genetics-in-medicine-study-demonstrates-the-benefits-of-proactive-exome-reanalysis-for-healthcare-equity 2025-10-10T08:52:44+00:00 https://ambrygen.com/company/press-release/159/ambry-genetics-announces-one-millionth-test-leveraging-rna-to-improve-diagnostic-accuracy-and-yield 2026-01-30T08:02:39+00:00 https://ambrygen.com/company/press-release/160/ambry-s-contributions-to-maves-support-thousands-of-patient-reclassifications-and-expand-to-new-genes 2026-06-17T07:21:31+00:00 https://ambrygen.com/company/press-release/28988/ambry-genetics-care-program-wins-2026-medtech-breakthrough-award-for-best-overall-health-informatics-solution 2026-07-31T13:43:19+00:00 https://ambrygen.com/company/press-release/28989/genetics-in-medicine-study-demonstrates-how-ambry-genetics-exomereveal-rna-testing-can-improve-diagnostic-clarity-in-exome-testing 2026-07-31T13:45:00+00:00